ShanXi C&Y Pharmaceutical Group Co., Ltd. announced earnings results for the full year ended December 31, 2020. For the full year, the company announced sales was CNY 848.072 million compared to CNY 1,131.801 million a year ago. Operating loss was CNY 315.111 million compared to CNY 41.117 million a year ago. Net loss was CNY 262.367 million compared to net income of CNY 5.296 million a year ago. Basic loss per share from continuing operations was CNY 1.2305 compared to basic earnings per share from continuing operations of CNY 0.0254 a year ago.